On Air Now

Current Show

Coast to Coast AM   12:00 AM - 5:00 AM

Contact Coast to Coast AM at 1-800-825-5033

Show Info »

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 550 AM Wausau, WI 99.9 FM Stevens Point, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
38° Feels Like: 34°
Wind: WNW 5 mph Past 24 hrs - Precip: 0.26”
Current Radar for Zip

Tonight

Rain 37°

Tomorrow

PM Showers 58°

Sat Night

Partly Cloudy 31°

Alerts

EU agency starts in-depth review of Ariad leukaemia drug

LONDON (Reuters) - European regulators have started an in-depth review of the benefits and risks of Ariad Pharmaceuticals Inc's leukaemia medicine Iclusig.

The European Medicines Agency (EMA) said on Friday the probe would look particularly at the risk of blood clots or blockages in the arteries or veins associated with the medicine.

Last month, the EMA reviewed the latest evidence about the drug and recommended continued use of Iclusig, though with a number of restrictions to help minimize risks.

That contrasts to the situation in the United States, where the drug has been suspended due to safety concerns.

Explaining the decision to launch the latest review, the EMA said a number of issues required further investigation and this had prompted the European Commission to ask for a further in-depth look at the drug.

(Reporting by Ben Hirschler; editing by Tom Pfeiffer)

Comments